Straumann Holding AG (OTCMKTS:SAUHY) Sees Significant Growth in Short Interest

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 13,401 shares, a growth of 336.1% from the December 15th total of 3,073 shares. Based on an average daily volume of 116,065 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 116,065 shares, the short-interest ratio is currently 0.1 days.

Straumann Stock Down 1.7%

Shares of Straumann stock opened at $12.42 on Wednesday. The stock’s fifty day moving average is $11.95 and its 200 day moving average is $11.97. Straumann has a one year low of $10.30 and a one year high of $15.07.

Wall Street Analyst Weigh In

SAUHY has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. Citigroup reaffirmed a “sell” rating on shares of Straumann in a report on Wednesday, October 22nd. The Goldman Sachs Group downgraded Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th. Finally, UBS Group raised Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.